Kawasaki disease associated with reactive hemophagocytic lymphohistiocytosis

Pediatric Infectious Disease Journal

Volumn 27, Issue 12, 2008, Pages 1116-1118

  Cummings, Christy ^a   Mccarthy, Paul ^a   Van Hoff, Jack ^b   Porter, George ^a  

^a Division of Cardiology   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

giant coronary artery aneurysms; Kawasaki disease; macrophage activation syndrome; perforin; Reactive hemophagocytic lymphohistiocytosis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSPORIN; ETOPOSIDE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PERFORIN; STEROID; T CELL COSTIMULATION MODULATOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ARTICLE; BONE MARROW BIOPSY; CANDIDEMIA; CASE REPORT; CD8+ T LYMPHOCYTE; CHILD; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NATURAL KILLER CELL; NEUTROPENIA; PANCYTOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; THROMBOCYTOPENIA; TREATMENT OUTCOME; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM;

CHILD; CORONARY ANEURYSM; HUMANS; KILLER CELLS, NATURAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERFORIN;

EID: 58149373650     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31817ecb6d     Document Type: Article

References (16)

1. Palazzi D, McClain K, Kaplan S. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J. 2003;22:663-666.
2. Grom A. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003;15: 587-590.
3. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002;14:548-552.
4. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421-426.
5. Muise A, Tallett S, Silverman E. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? J Pediatr. 2003;112:e495-e497.
6. Al-Eid W, Al-Jefri A, Buhabri S. Hemophagocytosis complicating Kawasaki disease. Pediatr Hematol Oncol. 2000;12:323-329.
7. Kaneko K, Takahashi K, Fujiwara S,Maluynma T, Obinata K. Kawasaki disease followed by hemophagocytic syndrome. Eur J Pediatr. 1998; 157:610-611.
8. Ohga S, Ooshima A, Fukushige A, Ueda K. Histiocytic Haemophago- cytosis in a patient with Kawasaki disease: changes in the hypercytoki- naemic state. Eur J Pediatr. 1995;154:539-541.
9. Hemophagocytic Lymphohistiocytosis Study Group. HLH-2004: Treatment Protocol of the Second International HLH Study. Stockholm, Sweden: Histiocytic Society; 2004.
10. Henter J, Horne A, Aricó M, et al. HLH-2004: Diagnostic and thera- peutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131.
11. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-2771.
12. Binstadt BA, Levine JC, Nigrovic PA, et al. Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic ar- thritis. Pediatrics. 2005;116:e89-e93.
13. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthri- tis. J Rheumatol. 2007;34:1133-1138.
14. Ericson KG, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590-597.
15. Feldmann J, Ménasché G, Callebaut I, et al. Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity. Blood. 2005;105:2658-2663.
16. Zur Stadt U, Beutel K, Kolberg S, et al. Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat. 2006;27:62-68.